MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Neuropsychological Evaluation of a Vietnamese-speaking Man with Parkinson’s Disease and Consideration for Deep Brain Stimulation Surgery: A Case Report

    B. Tran, K. Lawler (Philadelphia, PA, USA)

  • Neurorestorative effects of glycine transporter 1-inhibitor and D-Serine in a mouse model of nigrostriatal dopaminergic degeneration

    V. Francardo, Y. Schmitz, D. Sulzer, M.A. Cenci (Lund, Sweden)

  • Neurostructural alterations associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s disease

    C. Beal, V. Planche, C. Chassain, A. Marques, J.M. Bonny, B. Pereira, N. Vitello, M.L. Fantini, F. Durif (Clermont-Ferrand, France)

  • Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and Parkinson’s Disease: Preliminary report

    B. Lisewska, P. Lisewski, P. Szarwas, N. Piekuś-Słomka, D. Rość (Bydgoszcz, Poland)

  • New approach to assess changes in brain activation during real walking using EEG

    I. Maidan, S. Shustak, T. Shiner, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

  • New evidence for thalamic dysfunction in Parkinsonian rats

    L. Grandi, G. Di Giovanni, E. Fedele, G. Orban, A. Salvadè, W. Song, A. Stefani, A. Kaelin-Lang, S. Galati (Taverne, Switzerland)

  • New Nomenclature Of Genetic Myoclonus Syndromes

    S. Veen, R. Zutt, C. Klein, C. Marras, S. Berkovic, J. Caviness, H. Shibasaki, T. De Koning, M. Tijssen (Groningen, Netherlands)

  • Nigral stimulation for the treatment of refractory gait disturbances in Parkinson’s disease

    M. Carmona-Abellán, D. Moreno, M. Alegre, J. Guridi, R. Luquin (Pamplona, Spain)

  • Nilotinib for treating MSA: A preclinical proof of concept study

    P. Guerin, M. Lopez-Cuina, E. Bezard, W. Meissner, P-O. (Bordeaux, France)

  • NMSQ Application: A New Way to Access Non-Motor Symptoms in Patients with Parkinson’s Disease

    P. Lolekha, K. Kulkantrakorn (Pathumthani, Thailand)

  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 177
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley